IBD-Sleep: A Pilot Study Looking at Changes in Sleep Timing and IBD Symptoms
NCT06094608
Colitis, Colitis, Ulcerative
Ann Arbor, Michigan, United States
View Trial DetailsNCT Number: NCT03668249
The descriptive purpose of this study is to characterize clinical and nonclinical factors of participants with CD, participant flow and visits to other specialists in the hospitals of the healthcare network of the Autonomous Community of Madrid with implementation of electronic medical records. The clinical and nonclinical factors include: demographic and baseline clinical characteristics, lifestyle, relapses, complications, day hospital visits, surgery, presence of complications such as perianal fistulas and complex perianal fistulas. The predictive purpose of this study is to develop a statistical predictive model with the information obtained from the descriptive purpose, in the hospitals of the healthcare network of the Autonomous Community of Madrid, capable of assigning any participant diagnosed with CD a probability of reaching a prototypical clinical condition or a probability of experiencing certain clinical complications.
Looking for future studies?
Notify MeUp to 100 year
All sexes
Observational
HM Hospitales, Boadilla, Madrid, Spain
This is a retrospective and non-interventional study of participants with CD. The study will collect data from electronic medical records (EMRs) of the participants in the hospitals of the healthcare network of the Autonomous Community of Madrid with implementation of EMRs and will describe the determining factors and develop a statistical model for predicting likely outcomes in participants with CD. This study will conduct an additional substudy to evaluate the performance of the system through a human assessment to be performed by the clinical experts at each participating site.
The study will have a retrospective data collection from EMRs of the participants referring to last 5 years.
The study will enroll approximately 3000 participants. All participants will be enrolled in one observational cohort.
This multi-center trial will be conducted in Spain. The overall time for data collection in the study will be approximately 5 years.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Time frame: Approximately 5 years
Time frame: Approximately 5 years
Time frame: Approximately 5 years
Time frame: Approximately 5 years
Time frame: approximately 5 years
Time frame: Approximately 5 years
Time frame: Approximately 5 years
Time frame: Approximately 5 years
Development of a statistical predictive model capable of assigning any patient diagnosed with CD a probability of reaching a prototypical clinical condition or a probability of experiencing certain clinical complications.
Time frame: Approximately 5 years
Time frame: Approximately 5 years
Health care resources of participants with CD will be assessed in terms of direct and indirect resources. Direct resources will include number of hospital admissions, emergency and hospital visits, and tests performed, etc. Indirect resources related to decreased productivity of CD participants through a specific variable, the total number of work days lost due to CD during the study period.
Time frame: Approximately 5 years
Takeda
Industry
Characterization of a Multidimensional Model to Predict the Course of Crohn's Disease: A Pilot Study
Acronym: PREMONITION-CD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06094608
Colitis, Colitis, Ulcerative
Ann Arbor, Michigan, United States
View Trial DetailsNCT05642247
Biologics, Crohn Disease
Guangzhou, Guangdong, China
View Trial DetailsNCT04923100
Colitis, Colitis, Ulcerative
Guangzhou, Guangdong, China
View Trial DetailsNCT04647578
Colitis, Colitis, Ulcerative
Lille, France
View Trial Details